Free Trial

IN8bio (INAB) Earnings Date, Estimates & Call Transcripts

IN8bio logo
$0.22 -0.01 (-4.52%)
Closing price 03/25/2025 04:00 PM Eastern
Extended Trading
$0.22 +0.00 (+2.02%)
As of 07:38 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IN8bio Latest Earnings Summary

Latest Q4 2024
Earnings Date
Mar. 13Estimated
Actual EPS
(Mar. 13)
-$0.04 Beat By $0.03
Consensus EPS
(Mar. 13)
-$0.07

IN8bio released Q4 2024 earnings on March 13, 2025, reporting an EPS of -$0.04, which beat analysts' consensus estimates of -$0.07 by $0.03. With a trailing EPS of -$0.58, IN8bio's earnings are expected to grow next year, from ($0.56) to ($0.22) per share.

Get IN8bio Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IN8bio and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

INAB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

INAB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.
Remove Ads

IN8bio Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.07-$0.07-$0.07
Q2 20251-$0.07-$0.07-$0.07
Q3 20251-$0.06-$0.06-$0.06
Q4 20251-$0.05-$0.05-$0.05
FY 20254($0.25)($0.25)($0.25)
Remove Ads

IN8bio Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
3/13/2025Q4 2024-$0.07-$0.04+$0.03-$0.04--
11/12/2024--$0.14-$0.15 -$0.01-$0.15--
8/8/2024--$0.16-$0.19 -$0.03-$0.19--
5/9/2024Q1 2024-$0.17-$0.20 -$0.03-$0.20--
3/14/2024Q4 2023-$0.16-$0.21 -$0.05-$0.21--
11/9/2023Q3 2023-$0.25-$0.23+$0.02-$0.23--
8/10/2023Q2 2023-$0.28-$0.27+$0.01-$0.27--
5/12/2023Q1 2023-$0.33-$0.30+$0.03-$0.30--
3/30/2023Q4 2022-$0.28-$0.32 -$0.04-$0.32--

IN8bio Earnings - Frequently Asked Questions

IN8bio (NASDAQ:INAB) last announced its quarterly earning data on Thursday, March 13, 2025. Learn more on INAB's earnings history.

In the previous quarter, IN8bio (NASDAQ:INAB) reported ($0.04) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.07) by $0.03. Learn more on analysts' earnings estimate vs. INAB's actual earnings.

IN8bio (NASDAQ:INAB) has a recorded net income of -$30.01 million. INAB has generated -$0.58 earnings per share over the last four quarters.

IN8bio's earnings are expected to grow from ($0.56) per share to ($0.22) per share in the next year.

More Earnings Resources from MarketBeat

Remove Ads


This page (NASDAQ:INAB) was last updated on 3/26/2025 by MarketBeat.com Staff
From Our Partners